Cargando…
Targeting potassium channels for increasing delivery of imaging agents and therapeutics to brain tumors
Every year in the US, 20,000 new primary and nearly 200,000 metastatic brain tumor cases are reported. The cerebral microvessels/capillaries that form the blood–brain barrier not only protect the brain from toxic agents in the blood but also pose a significant hindrance to the delivery of small and...
Autores principales: | Khaitan, Divya, Ningaraj, Nagendra S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665941/ https://www.ncbi.nlm.nih.gov/pubmed/23755013 http://dx.doi.org/10.3389/fphar.2013.00062 |
Ejemplares similares
-
Role of KCNMA1 gene in breast cancer invasion and metastasis to brain
por: Khaitan, Divya, et al.
Publicado: (2009) -
Targeting GIRK Channels for the Development of New Therapeutic Agents
por: Walsh, Kenneth B.
Publicado: (2011) -
Editorial: Lymphatic delivery and targeting of drugs, vaccines, and imaging agents
por: Han, Sifei, et al.
Publicado: (2022) -
Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
por: Chulpanova, Daria S., et al.
Publicado: (2018) -
Voltage Sensor Inactivation in Potassium Channels
por: Bähring, Robert, et al.
Publicado: (2012)